Insider · CIK 0001015823
Parag Saxena
Files at RVPH (REVIVA PHARMACEUTICALS HOLDINGS, INC.). First filing -, latest -.
In brief
Parag Saxena files SEC Form 4 as director and 10% owner at RVPH (REVIVA PHARMACEUTICALS HOLDINGS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Parag Saxena has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | AGrant or award Stock Option (right to buy)derivative | +8,200 | $0.00 | $0 | 8,200 | Dec 19, 2025 |
| Dec 10, 2024 | RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | AGrant or award Stock Option (right to buy)derivative | +8,200 | $0.00 | $0 | 8,200 | Dec 12, 2024 |
Questions about Parag Saxena
Answered from the filings on this page, as of the latest one.
Is Parag Saxena buying or selling?
Parag Saxena has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Parag Saxena's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Parag Saxena has 0.
Where does Parag Saxena file Form 4?
Parag Saxena has filed Form 4 at RVPH (REVIVA PHARMACEUTICALS HOLDINGS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.